Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.

Name: Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.
Author: Ko, Jae-Hoon

Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients. — المؤلف: Ko, Jae-Hoon — Journal of Korean medical science 20190419

المؤلف: Ko, Jae-Hoon
النشر: Journal of Korean medical science 20190419
الوصف: e17 p.
الموضوعات: Amikacin؛ Anti-Bacterial Agents؛ Carbapenems؛ Drug Resistance, Bacterial؛ Enterobacteriaceae؛ Febrile Neutropenia؛ Humans؛ Piperacillin, Tazobactam Drug Combination